Elemeno Health (1)

Elemeno Health (1)

Empowering staff at the point of care: Improving safety, and fighting COVID

Print
Follow
Security Type
Crowd SAFE
Min Investment
$100
Location
Oakland, CA
Offering Date
April 13, 2020
Expected Close Date
April 30, 2020
Target Raise
$25.00K-$1.07M
Deal Notes

Discount: 0%

Company Description

We expect our doctors and nurses to deliver the best care possible, but medical practices are constantly changing. This is the knowledge-practice gap, and we have been closing it for our clients for three years. With COVID-19, change is moving even faster—from national guidelines, to regional resources, to hospital-specific workflows. The information explosion is happening across the globe now, and none of it is organized—except at our clients. Traditional staff meetings, group emails and bloated reports do not work, especially in the context of media noise. Staff are anxious and feel inadequately prepared. Patient care is inconsistent. Frontline staff are falling ill. As the surge is hitting, our healthcare workforce is straining. The world needs Elemeno now.

Key Deal Facts

Microlearning safety solution: elevate quality, empower staff, engage teams
Supporting frontline teams in the fight against COVID-19 nationwide
$900K+ in revenue to date | $8.3M+ projected annual revenue by 2022
$2.9M in funding, including Launchpad Digital Health & Y Combinator (S16)
$2B addressable market in clinical operations alone
Multiple award-winner | Partnerships with 10+ hospitals across the US

Use of Proceeds

  • Sales & Marketing: 63%
  • Research & Development: 31%
  • Intermediary Fee: 6%

Deal Notes

Discount: 0%

Amount Raised : $1,070,000
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments